DEEPALI SHARMA M.D. NPI 1306058581

NPI Details

Deepali Sharma, M.D. is a hematology and oncology internal medicine in Riverhead, NY with 27 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Deepali Sharma, M.D. NPI is 1306058581. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

750 OLD COUNTRY ROAD BUILDING 2
RIVERHEAD, NY
ZIP 11901
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1306058581 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Phosphate level (HCPCS:84100)
• Magnesium level (HCPCS:83735)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Uric acid level, blood (HCPCS:84550)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, romiplostim, 10 micrograms (HCPCS:J2796)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Vitamin d-3 level (HCPCS:82306)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Red blood count, manual test (HCPCS:85044)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Folic acid level, serum (HCPCS:82746)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Protein measurement, serum (HCPCS:84165)
• Injection of drug or substance into vein (HCPCS:96374)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Blood test, clotting time (HCPCS:85610)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Ige (immune system protein) level (HCPCS:82785)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Urinalysis, manual test (HCPCS:81002)
• Testosterone (hormone) level, total (HCPCS:84403)
• Hemoglobin a1c level (HCPCS:83036)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Drawing of blood for a medical problem (HCPCS:99195)
• Acute hepatitis panel (HCPCS:80074)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Red blood cell concentration measurement (HCPCS:85014)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Phosphatase (enzyme) measurement, acid, total (HCPCS:84060)
• Bilirubin level, total (HCPCS:82247)
• Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Rheumatoid factor level (HCPCS:86431)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Cholesterol level (HCPCS:82465)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Blood smear for iron (HCPCS:85536)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Triglycerides level (HCPCS:84478)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Stool analysis for blood to screen for colon tumors (HCPCS:82270)

The enumeration date for this NPI number is 5/3/2007 and was last updated on 2/3/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.